{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T01:51:06Z","timestamp":1794102666044,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["RO1CA252239"],"award-info":[{"award-number":["RO1CA252239"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA228135"],"award-info":[{"award-number":["R01CA228135"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA242020"],"award-info":[{"award-number":["R01CA242020"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["RO1CA266212"],"award-info":[{"award-number":["RO1CA266212"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1K22CA258520-01"],"award-info":[{"award-number":["1K22CA258520-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1P50 254838-01"],"award-info":[{"award-number":["1P50 254838-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health; Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA197695"],"award-info":[{"award-number":["CA197695"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["5468-18"],"award-info":[{"award-number":["5468-18"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Curing Kids Cancer Vogelstein Foundation"},{"DOI":"10.13039\/100009141","name":"Cancer League of Colorado","doi-asserted-by":"publisher","award":["AWD#222549"],"award-info":[{"award-number":["AWD#222549"]}],"id":[{"id":"10.13039\/100009141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Jeffrey Pride Foundation for Pediatric Cancer Research and the Children\u2019s Oncology Group Foundation"},{"name":"Parker Institute for Cancer immunotherapy and the Grand Multiple Myeloma Translational Initiative"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1F32HD078029-01A1"],"award-info":[{"award-number":["1F32HD078029-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P01 GM099134"],"award-info":[{"award-number":["P01 GM099134"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA251138"],"award-info":[{"award-number":["R01 CA251138"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA242020"],"award-info":[{"award-number":["R01 CA242020"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health; Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM133646"],"award-info":[{"award-number":["R35GM133646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council (NHMRC) of Australia"},{"DOI":"10.13039\/501100005302","name":"Alexander S. Onassis Public Benefit Foundation","doi-asserted-by":"publisher","award":["F ZP 036-1\/2019-2020"],"award-info":[{"award-number":["F ZP 036-1\/2019-2020"]}],"id":[{"id":"10.13039\/501100005302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex\u2019s Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gerald and Darlene Jordan Chair in Regenerative Medicine"},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["CRI4018"],"award-info":[{"award-number":["CRI4018"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henry Schueler 41&9 Foundation"},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET 2103219"],"award-info":[{"award-number":["CBET 2103219"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41590-022-01314-y","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T12:12:59Z","timestamp":1663848779000},"page":"1424-1432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"23","author":[{"given":"Matthew T.","family":"Witkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soobeom","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6734-413X","authenticated-orcid":false,"given":"Alexis","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tsopoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Brumbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8230-5312","authenticated-orcid":false,"given":"Yaqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn G.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3170-839X","authenticated-orcid":false,"given":"Simon J.","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Nomikou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohana E.","family":"Ghebrechristos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9881-3645","authenticated-orcid":false,"given":"Palaniraja","family":"Thandapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5811-5386","authenticated-orcid":false,"given":"Konrad","family":"Hochedlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-8328","authenticated-orcid":false,"given":"Weiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3907-6171","authenticated-orcid":false,"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-1190","authenticated-orcid":false,"given":"Justin","family":"Eyquem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-1035","authenticated-orcid":false,"given":"Iannis","family":"Aifantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"key":"1314_CR1","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","volume":"5","author":"E Sotillo","year":"2015","unstructured":"Sotillo, E. et al. Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov. 5, 1282\u20131295 (2015).","journal-title":"Cancer Discov."},{"key":"1314_CR2","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/s41591-018-0146-z","volume":"24","author":"EJ Orlando","year":"2018","unstructured":"Orlando, E. J. et al. Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia. Nat. Med. 24, 1504\u20131506 (2018).","journal-title":"Nat. Med."},{"key":"1314_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1182\/blood.2020006287","volume":"137","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL. Blood 137, 471\u2013484 (2021).","journal-title":"Blood"},{"key":"1314_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07901-8","volume":"9","author":"KR Sanson","year":"2018","unstructured":"Sanson, K. R. et al. Optimized libraries for CRISPR\u2013Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416 (2018).","journal-title":"Nat. Commun."},{"key":"1314_CR5","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.4049\/jimmunol.149.9.2841","volume":"149","author":"LE Bradbury","year":"1992","unstructured":"Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L. & Tedder, T. F. The CD19\/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149, 2841\u20132850 (1992).","journal-title":"J. Immunol."},{"key":"1314_CR6","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.4049\/jimmunol.171.8.4062","volume":"171","author":"T Shoham","year":"2003","unstructured":"Shoham, T. et al. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment. J. Immunol. 171, 4062\u20134072 (2003).","journal-title":"J. Immunol."},{"key":"1314_CR7","doi-asserted-by":"publisher","first-page":"9585","DOI":"10.1016\/S0021-9258(18)98391-2","volume":"268","author":"V David","year":"1993","unstructured":"David, V., Hochstenbach, F., Rajagopalan, S. & Brenner, M. B. Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin). J. Biol. Chem. 268, 9585\u20139592 (1993).","journal-title":"J. Biol. Chem."},{"key":"1314_CR8","first-page":"1958","volume":"125","author":"S Lang","year":"2012","unstructured":"Lang, S. et al. Different effects of Sec61alpha, Sec62 and Sec63 depletion on transport of polypeptides into the endoplasmic reticulum of mammalian cells. J. Cell Sci. 125, 1958\u20131969 (2012).","journal-title":"J. Cell Sci."},{"key":"1314_CR9","first-page":"2662","volume":"12","author":"Z Kozmik","year":"1992","unstructured":"Kozmik, Z., Wang, S., Dorfler, P., Adams, B. & Busslinger, M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell Biol. 12, 2662\u20132672 (1992).","journal-title":"Mol. Cell Biol."},{"key":"1314_CR10","doi-asserted-by":"crossref","unstructured":"Cort\u00e9s-L\u00f3pez, M. et al. High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance. Preprint at bioRxiv https:\/\/doi.org\/2021.2010.2008.463671 (2021).","DOI":"10.1101\/2021.10.08.463671"},{"key":"1314_CR11","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.cell.2017.11.008","volume":"171","author":"AS Weintraub","year":"2017","unstructured":"Weintraub, A. S. et al. YY1 Is a structural regulator of enhancer\u2013promoter loops. Cell 171, 1573\u20131588.e1528 (2017).","journal-title":"Cell"},{"key":"1314_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7186","volume":"2","author":"SD Bailey","year":"2015","unstructured":"Bailey, S. D. et al. ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nat. Commun. 2, 6186 (2015).","journal-title":"Nat. Commun."},{"key":"1314_CR13","doi-asserted-by":"publisher","first-page":"21998","DOI":"10.1074\/jbc.273.34.21998","volume":"273","author":"E Myslinski","year":"1998","unstructured":"Myslinski, E., Krol, A. & Carbon, P. ZNF76 and ZNF143 are two human homologs of the transcriptional activator Staf. J. Biol. Chem. 273, 21998\u201322006 (1998).","journal-title":"J. Biol. Chem."},{"key":"1314_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"1314_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20282-1","volume":"12","author":"Q Zhou","year":"2021","unstructured":"Zhou, Q. et al. ZNF143 mediates CTCF-bound promoter\u2013enhancer loops required for murine hematopoietic stem and progenitor cell function. Nat. Commun. 12, 43 (2021).","journal-title":"Nat. Commun."},{"key":"1314_CR16","doi-asserted-by":"crossref","unstructured":"Witkowski, M.T. et al. Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia. Cancer Cell 37, 867\u2013882 (2020).","DOI":"10.1016\/j.ccell.2020.04.015"},{"key":"1314_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41587-020-0456-9","volume":"38","author":"HH Wessels","year":"2020","unstructured":"Wessels, H. H. et al. Massively parallel Cas13 screens reveal principles for guide RNA design. Nat. Biotechnol. 38, 722\u2013727 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1314_CR18","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.1073\/pnas.1000848107","volume":"107","author":"Q Yang","year":"2010","unstructured":"Yang, Q., Gilmartin, G. M. & Doublie, S. Structural basis of UGUA recognition by the Nudix protein CFI(m)25 and implications for a regulatory role in mRNA 3\u2032 processing. Proc. Natl Acad. Sci. USA 107, 10062\u201310067 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1314_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrg3662","volume":"15","author":"DL Bentley","year":"2014","unstructured":"Bentley, D. L. Coupling mRNA processing with transcription in time and space. Nat. Rev. Genet. 15, 163\u2013175 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"1314_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2017.12.035","volume":"172","author":"J Brumbaugh","year":"2018","unstructured":"Brumbaugh, J. et al. Nudt21 controls cell fate by connecting alternative polyadenylation to chromatin signaling. Cell 172, 629\u2013631 (2018).","journal-title":"Cell"},{"key":"1314_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2017.09.026","volume":"410","author":"M Sun","year":"2017","unstructured":"Sun, M. et al. NUDT21 regulates 3\u2032-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma. Cancer Lett. 410, 158\u2013168 (2017).","journal-title":"Cancer Lett."},{"key":"1314_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/biom10060915","volume":"10","author":"J Nourse","year":"2020","unstructured":"Nourse, J., Spada, S. & Danckwardt, S. Emerging roles of RNA 3\u2032-end cleavage and polyadenylation in pathogenesis, diagnosis and therapy of human disorders. Biomolecules 10, 915 (2020).","journal-title":"Biomolecules"},{"key":"1314_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-19-0945","volume":"10","author":"RG Majzner","year":"2020","unstructured":"Majzner, R. G. et al. Tuning the antigen density requirement for CAR T-cell activity. Cancer Discov. 10, 702\u2013723 (2020).","journal-title":"Cancer Discov."},{"key":"1314_CR24","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-18-3784","volume":"25","author":"S Ramakrishna","year":"2019","unstructured":"Ramakrishna, S. et al. Modulation of target antigen density improves CAR T-cell functionality and persistence. Clin. Cancer Res. 25, 5329\u20135341 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1314_CR25","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1182\/bloodadvances.2019000692","volume":"3","author":"V Pillai","year":"2019","unstructured":"Pillai, V. et al. CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy. Blood Adv. 3, 3539\u20133549 (2019).","journal-title":"Blood Adv."},{"key":"1314_CR26","doi-asserted-by":"publisher","first-page":"eaba5536","DOI":"10.1126\/sciadv.aba5536","volume":"6","author":"C Ma","year":"2020","unstructured":"Ma, C. et al. Leukemia-on-a-chip: dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche. Sci. Adv. 6, eaba5536 (2020).","journal-title":"Sci. Adv."},{"key":"1314_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","volume":"543","author":"J Eyquem","year":"2017","unstructured":"Eyquem, J. et al. Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection. Nature 543, 113\u2013117 (2017).","journal-title":"Nature"},{"key":"1314_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21168-6","volume":"12","author":"T Rabilloud","year":"2021","unstructured":"Rabilloud, T. et al. Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy. Nat. Commun. 12, 865 (2021).","journal-title":"Nat. Commun."},{"key":"1314_CR29","doi-asserted-by":"crossref","unstructured":"Wang, E. et al. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation. Cell Stem Cell 28, 718\u2013731 (2021).","DOI":"10.1016\/j.stem.2020.12.005"},{"key":"1314_CR30","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1182\/bloodadvances.2019001346","volume":"4","author":"P Ramkumar","year":"2020","unstructured":"Ramkumar, P. et al. CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Blood Adv. 4, 2899\u20132911 (2020).","journal-title":"Blood Adv."},{"key":"1314_CR31","doi-asserted-by":"crossref","unstructured":"Li, S., Ilaria, R.L., Million, R.P., Daley, G.Q. & Van Etten, R.A. The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189, 1399\u20131412 (1999).","DOI":"10.1084\/jem.189.9.1399"},{"key":"1314_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nbt.3235","volume":"33","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Discovery of cancer drug targets by CRISPR\u2013Cas9 screening of protein domains. Nat. Biotechnol. 33, 661\u2013667 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1314_CR33","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR\u2013Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"1314_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR\u2013Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1314_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-4939-7204-3_14","volume":"1648","author":"EL Van Nostrand","year":"2017","unstructured":"Van Nostrand, E. L. et al. Robust, cost-effective profiling of RNA binding protein targets with single-end enhanced crosslinking and immunoprecipitation (seCLIP). Methods Mol. Biol. 1648, 177\u2013200 (2017).","journal-title":"Methods Mol. Biol."},{"key":"1314_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/epi.26931","volume":"9","author":"AM Zawada","year":"2014","unstructured":"Zawada, A. M. et al. Massive analysis of cDNA ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease. Epigenetics 9, 161\u2013172 (2014).","journal-title":"Epigenetics"},{"key":"1314_CR37","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u201397 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1314_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1314_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1314_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-3387-6","volume":"18","author":"C Lazaris","year":"2017","unstructured":"Lazaris, C., Kelly, S., Ntziachristos, P., Aifantis, I. & Tsirigos, A. HiC-bench: comprehensive and reproducible Hi-C data analysis designed for parameter exploration and benchmarking. BMC Genom. 18, 22 (2017).","journal-title":"BMC Genom."},{"key":"1314_CR41","doi-asserted-by":"publisher","unstructured":"Li, H.W. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1303.3997 (2013).","DOI":"10.48550\/arXiv.1303.3997"},{"key":"1314_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41588-020-0602-9","volume":"52","author":"A Kloetgen","year":"2020","unstructured":"Kloetgen, A. et al. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia. Nat. Genet. 52, 388\u2013400 (2020).","journal-title":"Nat. Genet."},{"key":"1314_CR43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41586-020-2077-3","volume":"583","author":"EL Van Nostrand","year":"2020","unstructured":"Van Nostrand, E. L. et al. A large-scale binding and functional map of human RNA-binding proteins. Nature 583, 711\u2013719 (2020).","journal-title":"Nature"},{"key":"1314_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 27, 491\u2013499 (2017).","journal-title":"Genome Res."},{"key":"1314_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1364-2","volume":"18","author":"S Krakau","year":"2017","unstructured":"Krakau, S., Richard, H. & Marsico, A. PureCLIP: capturing target-specific protein\u2013RNA interaction footprints from single-nucleotide CLIP-seq data. Genome Biol. 18, 240 (2017).","journal-title":"Genome Biol."},{"key":"1314_CR46","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","volume":"38","author":"GH Putri","year":"2022","unstructured":"Putri, G. H., Andres, S., Pyl, P. T., Pimanda, J. E. & Zanini, F. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinformatics 38, 2943\u20132945 (2022).","journal-title":"Bioinformatics"},{"key":"1314_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1414-4","volume":"19","author":"KCH Ha","year":"2018","unstructured":"Ha, K. C. H., Blencowe, B. J. & Morris, Q. QAPA: a new method for the systematic analysis of alternative polyadenylation from RNA-seq data. Genome Biol. 19, 45 (2018).","journal-title":"Genome Biol."},{"key":"1314_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"1314_CR49","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow, J. et al. GENCODE: the reference human genome annotation for the ENCODE Project. Genome Res. 22, 1760\u20131774 (2012).","journal-title":"Genome Res."},{"key":"1314_CR50","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1101\/gr.202432.115","volume":"26","author":"AJ Gruber","year":"2016","unstructured":"Gruber, A. J. et al. A comprehensive analysis of 3\u2032 end sequencing data sets reveals novel polyadenylation signals and the repressive role of heterogeneous ribonucleoprotein C on cleavage and polyadenylation. Genome Res. 26, 1145\u20131159 (2016).","journal-title":"Genome Res."},{"key":"1314_CR51","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen, S. et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc. Natl Acad. Sci. USA 111, E5593\u2013E5601 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1314_CR52","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"1314_CR53","doi-asserted-by":"crossref","unstructured":"Dann, E., Henderson, N.C., Teichmann, S.A., Morgan, M.D. & Marioni, J.C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 40, 245\u2013253 (2021).","DOI":"10.1038\/s41587-021-01033-z"},{"key":"1314_CR54","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"1314_CR55","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive Integration of single-cell data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01314-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01314-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01314-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:03:15Z","timestamp":1781172195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01314-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1038\/s41590-022-01314-y","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"5 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.A. is a consultant for Foresite Labs and receives research funding from AstraZeneca. A.T. is a scientific advisor to Intelligencia AI. M.T.W has received royalties from the Walter and Eliza Hall Institute for the development of venetoclax unrelated to the current manuscript. O.A.-W. has served as a consultant for H3B Biomedicine, Foundation Medicine Inc., Merck, Prelude Therapeutics and Janssen and is on the Scientific Advisory Board of Envisagenics Inc., AIChemy, Harmonic Discovery Inc. and Pfizer Boulder. He has received previous research funding from H3B Biomedicine and LOXO Oncology unrelated to the current manuscript. C.G.M. receives research support from AbbVie and Pfizer, is a member of the advisory boards of Faze, Beam and Illumina and has accepted speaking fees from Amgen. J.E. is a compensated co-founder at Mnemo Therapeutics and a compensated scientific advisor to Cytovia Therapeutics, owns stocks in Mnemo Therapeutic and Cytovia Therapeutics and has received a consulting fee from Casdin Capital. He is also a holder of patents pertaining to but not resulting from this work. J.E.\u2019s lab has received research support from Cytovia Therapeutic, Mnemo Therapeutics and Takeda. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}